Summary
We here aimed to investigate the impact of gender on the clinical characteristics and laboratory results of patients with coronavirus disease 2019 (COVID-19) and provide clues to the pathological mechanisms underlying COVID-19. A retrospective study was performed. Clinical characteristics, severity of lung infection, laboratory results, and prognoses of patients of different gender were analyzed. A total of 242 patients were finally included. The median age was 58 years (IQR: 40–68), including 54 (22.3%) hospital staffs. Ninety-four (38.8%) were male and 148 (61.1%) were female. The proportion of patients with diabetes was significantly higher in the male group than in the female group (P=0.034). Male patients had a significantly larger proportion of severe lung infection, higher leukocyte count, neutrophil count, neutrophil-to-lymphocyte ratio, C-reactive protein, and procalcitonin than female. Furthermore, male patients had worse liver, cardiac, and coagulation function than their female counterparts. Male patients with COVID-19 showed more severe inflammation reaction and coagulation dysfunction than female patients. In conclusion, gender is associated with host response to SARS-CoV-2 infection.
Article PDF
Similar content being viewed by others
References
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med, 2020,382(18):1708–1720
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, China: A retrospective cohort study. Lancet, 2020,395(10229):1054–1062
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in wuhan, China. Lancet, 2020, 395(10223):497–506
Jin JM, Bai P, He W, et al. Gender differences in patients with COVID-19: Focus on severity and mortality. Front Public Health 2020,8(152):1–6
Epidemiology working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi (Chinese), 2020,41(2):145–151
Ortolan A, Lorenzin M, Felicetti M, et al. Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis. Int J Infect Dis, 2020,99:496–504
Spagnolo PA, Manson JE, Joffe H. Sex and gender differences in health: What the COVID-19 pandemic can teach us. Ann Intern Med, 2020,173(5):385–386
Diagnosis and treatment program of 2019 new coronavirus pneumonia (trial seventh version). (Chinese). 2020 (http://www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf)
Clinical management of COVID-19. 2020 (https://apps.who.int/iris/rest/bitstreams/1278777/retrieve)
Chinese Research Hospital Association Standing Committee on Infection and Inflammation, et al. Guideline for imaging diagnosis of novel coronavirus(2019-ncov) infected pneumonia (2nd edition 2020). Shoudu Yike Daxue Xuebao (Chinese). 2020,41(2):168–173
Mohamed MO, Gale CP, Kontopantelis E, et al. Sex differences in mortality rates and underlying conditions for COVID-19 deaths in england and wales. Mayo Clin Proc, 2020,95(10):2110–2124
Anca PS, Toth PP, Kempler P, et al. Gender differences in the battle against COVID-19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes. Int J Clin Pract, 2020,75(2):e13666
Haitao T, Vermunt JV, Abeykoon J, et al. COVID-19 and sex differences: Mechanisms and biomarkers. Mayo Clin Proc, 2020,95(10):2189–2203
Li Y, Jerkic M, Slutsky AS, et al. Molecular mechanisms of sex bias differences in COVID-19 mortality. Crit Car, 2020,24(1):405
Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. Eur Respir J, 2020,55(5):2000547
Lauc G, Sinclair D. Biomarkers of biological age as predictors of COVID-19 disease severity. Aging (Albany NY), 2020,12(8):6490–6491
The Lancet. The gendered dimensions of COVID-19. Lancet, 2020,395(10231):1168
Markle JG, Fish EN. Sex matters in immunity. Trends Immunol, 2014,35(3):97–104
Maggi E, Canonica GW, Moretta L. COVID-19: Unanswered questions on immune response and pathogenesis. J Allergy Clin Immunol, 2020,146(1):18–22
Wakeman L, Al-Ismail S, Benton A, et al. Robust, routine haematology reference ranges for healthy adults. Int J Lab Hematol, 2007,29(4):279–283
Qiao R, Yang S, Yao B, et al. Complete blood count reference intervals and age- and sex-related trends of north China han population. Clin Chem Lab Med, 2014,52(7):1025–1032
Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in wuhan, China. Clin Infect Dis. 2020,71(15):762–768
Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020,95(7):834–847
Akhmerov A, Marban E. COVID-19 and the heart. Circ Res. 2020,126(10):1443–1455
Tay MZ, Poh CM, Renia L, et al. The trinity of COVID-19: Immunity, inflammation and intervention. Nat Rev Immunol. 2020,20(6):363–374
Salamanna F, Maglio M, Landini MP, et al. Platelet functions and activities as potential hematologic parameters related to coronavirus disease 2019 (COVID-19). Platelets, 2020,31(5):627–632.
Weidhofer C, Meyer E, Ristl R, et al. Dynamic reference intervals for coagulation parameters from infancy to adolescence. Clin Chim Acta. 2018,482:124–135
Cai H. Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir Med, 2020,8(4): e20
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflict of Interest Statement
The authors declare that there is no conflict of interest with any financial organization or corporation or individual that can inappropriately influence this work.
This work was supported by the National Natural Science Foundation of China (Nos. 81570416, 81570337), Hubei Province Health and Family Planning Scientific Research Project (No. WJ2019M120), Natural Science Foundation of Hubei Province (No. 2019CFB668), the Fundamental Research Fund for the Central Universities (HUST) (No. 2017KFYXJJ099), the Science and Technology Project Foundation of Wuhan (No. 2017060201010175), and the Outstanding Young Investigator Foundation of Tongji Hospital (No. YXQN009).
Rights and permissions
About this article
Cite this article
Shi, Mj., Lv, Jg., Lin, L. et al. Trends in Coronavirus Disease 2019 Hospitalization and Prognosis: Gender Effect. CURR MED SCI 41, 312–317 (2021). https://doi.org/10.1007/s11596-021-2348-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-021-2348-8